Biotech Park (Formulation I & II)OVERVIEW
| Established in the year: | 2003 |
| Facility Area: | |
| Formulation - I: | 915
m2 | | Formulation
- II: | 1,240 m2 | | Dosage
forms: | Glass Vials
Plastic Vials (Ophthalmic)
Glass Cartridges
Glass Pre-filled Syringes | | Regulatory
approval: | MHRA / USFDA |
Wockhardt's Biotech Park operations in India feature two separate sterile areas
housing various aseptically filled sterile injectable and ophthalmic capabilities.
Utilising state-of-the-art equipment, the Biotech Park is able to offer a comprehensive
range of sizes for all specified dosage forms.
Qualified Persons release
product for European and US markets through our Wockhardt UK facility. | 
